Boundaries between normal and abnormal are often thin and blurred
Each individual's experiences, genetics, and environment create a unique mental health landscape. What may appear as a debilitating condition for one person could.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Each individual's experiences, genetics, and environment create a unique mental health landscape. What may appear as a debilitating condition for one person could.
Post-pandemic, the Hamlet-like dilemma of ‘work from office or work from home’ has led to a battle of push and pull. Many corporates.
HQ Team January 6, 2025: Suicide remains a pressing global public health issue, with over 700,000 deaths annually. A recent study highlighted significant social determinants.
HQ Team January 4, 2025: A new study reveals that genetic testing can identify which antifungal drugs will effectively treat patients with Candida.
Bharti Jayshankar January 4, 2024: A sense of bereavement is a common emotional response to the loss of a near and dear one..
HQ Team December 30, 2024: The global prevalence and health burden of autism spectrum disorder (ASD) are high, according to a review published.
HQ Team December 28, 2024: A study from Taiwan links the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy, with a potential risk.
Bharti Jayshankar December 28, 2024: A recent research reveals that certain symptoms precede a diagnosis of multiple sclerosis (MS) in pediatric patients. The.
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial.